The Vertical Group

The Vertical Group is a US venture capital firm based in Summit, New Jersey, with a long history of investing exclusively in medical technology and biotechnology companies. The firm does not stretch into adjacent categories — no health IT, no services, no consumer wellness. AI is not a focus; what the firm brings is a narrow, repeated playbook for early-stage device and biotech founders, including a team that has presumably seen many similar product, regulatory, and clinical paths.

The fund writes $1M to $5M checks at Seed and Series A, which positions it to lead small early rounds or co-invest alongside larger MedTech and biotech specialists. The capital range fits a typical first institutional check for device or biotech companies still gathering early clinical or preclinical proof points.

Founders should approach The Vertical Group when their company is unambiguously a medical device or biotech play, with clear regulatory and clinical milestones in view. Digital health, services, consumer wellness, and software-only platforms will not be the right audience. Because the firm has stayed in its lane for a long time, expect partners who know the standard early-stage pitfalls in MedTech and biotech and who will press on regulatory strategy, IP, and the credibility of clinical milestones. Founders should arrive with a tight technical thesis, a defensible IP position, and a realistic timeline to the next value-inflection point rather than a broad healthcare narrative.